Compositions and methods for targeted in vitro and in vivo drug delivery to mammalian cells via bacterially derived intact minicells

Details for Australian Patent Application No. 2010200599 (hide)

Owner Engeneic Molecular Delivery Pty Ltd.

Inventors Brahmbhatt, Himanshu; MacDiarmid, Jennifer

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2010200599

Parent 2005215254

Filing date 5 February 2010

Wipo publication date 11 March 2010

Acceptance publication date 22 September 2011

International Classifications

A61K 47/00 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

A61K 9/50 (2006.01) Medicinal preparations characterised by special physical form - Microcapsules

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

Event Publications

4 March 2010 Complete Application Filed

11 March 2010 Application Open to Public Inspection

  Published as AU-B-2010200599

22 September 2011 Application Accepted

  Published as AU-B-2010200599

19 January 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010200600-Synthesis of a novel nitroxide antioxidant and methods of use in cosmetic and dermatological compositions

2010200598-Turning motion assistance device for electric vehicle